Senior Accountant
CRISPR Therapeutics
Summary
This position is a key role within the Finance group that will support various aspects of finance and accounting for the Company. The ideal candidate will have strong knowledge of U.S. GAAP and be effective in a general accounting function. The position requires a solid accounting background combined with strong analytical skills. This is an excellent opportunity to build one's accounting skills as part of a high-performing, collaborative team, with broad exposure to all aspects of the Company's business. This role requires a candidate who is familiar with general accounting responsibilities and general ledger activities, including journal entries, intercompany transactions and account reconciliations.
Job description
Position Summary
This position is a key role within the Finance group that will support various aspects of finance and accounting for the Company. The ideal candidate will have strong knowledge of U.S. GAAP and be effective in a general accounting function. The position requires a solid accounting background combined with strong analytical skills. This is an excellent opportunity to build one's accounting skills as part of a high-performing, collaborative team, with broad exposure to all aspects of the Company's business. This role requires a candidate who is familiar with general accounting responsibilities and general ledger activities, including journal entries, intercompany transactions and account reconciliations.
Responsibilities
- Support the team with the month-end close, including the preparation of journal entries and monthly schedules, such as balance sheet and payroll reconciliations.
- Support post-close activities, including working with FP&A and cross-functional team members to explain variances and fluctuations in the financial results.
- Manage day-to-day cash operations, including monitoring bank balances and preparing bank reconciliations.
- Support the annual audit and quarterly reviews by preparing schedules, gathering supporting documentation and completing other auditor requests.
- Help design and maintain processes that strengthen internal controls over financial reporting.
- Assist with the preparation of certain disclosure schedules for SEC reporting documents (e.g., Forms 10-Q and 10-K and the proxy statement).
- Complete assigned ad hoc projects, including reviewing existing procedures to identify improvements that optimize resource use while maintaining accuracy.
- Support Accounts Payable as needed, including data analysis, payment processing and other day-to-day activities.
Minimum Qualifications
- Bachelor's degree required; degree in Accounting and corporate accounting experience strongly preferred.
- Minimum of 4+ years of accounting experience, preferably in the life sciences industry, or advanced degree and 2+ years of relevant experience.
- Ability to manage high volumes of data with accuracy and efficiency, supported by strong Microsoft Excel skills.
- Excellent verbal and written communication skills.
- Self-motivated and detail-oriented, with the ability to work independently in a fast-paced, dynamic environment.
Preferred Qualifications
- CPA preferred
- Experience in public accounting or at a public life sciences company.
- Experience with Oracle Fusion or equivalent ERP systems.
Requirements
- Bachelor's degree required
- Degree in Accounting and corporate accounting experience strongly preferred
- Minimum of 4+ years of accounting experience, preferably in the life sciences industry, or advanced degree and 2+ years of relevant experience
- Ability to manage high volumes of data with accuracy and efficiency
- Strong Microsoft Excel skills
- Excellent verbal and written communication skills
- Self-motivated and detail-oriented
- Ability to work independently in a fast-paced, dynamic environment
- CPA preferred
- Experience in public accounting or at a public life sciences company
- Experience with Oracle Fusion or equivalent ERP systems
Benefits
- Bonus
- Equity
- Benefits
Company overview
CRISPR Therapeutics AG is a pioneering Swiss-American biotechnology company founded in 2013 that specializes in developing transformative gene-based medicines using the revolutionary CRISPR/Cas9 gene editing platform. Headquartered in Zug, Switzerland with major R&D operations in Boston, Massachusetts and San Francisco, California, the company was co-founded by Nobel Prize winner Emmanuelle Charpentier and represents one of the first commercial entities to harness CRISPR technology for therapeutic applications. CRISPR Therapeutics achieved a historic milestone in December 2023 with the FDA approval of CASGEVY® (exagamglogene autotemcel), the world's first CRISPR-based therapy for treating sickle cell disease and transfusion-dependent beta thalassemia. The company maintains a diverse pipeline targeting hemoglobinopathies, oncology, regenerative medicine, cardiovascular diseases, autoimmune disorders, and rare genetic conditions. Through strategic partnerships with industry leaders like Vertex Pharmaceuticals and Bayer, CRISPR Therapeutics continues to advance its innovative platform, employing approximately 400 professionals globally and maintaining a strong financial position with over $1.8 billion in cash and marketable securities as of 2025.